Out-of-pocket costs from diagnostic testing after prostate cancer screening are common and rising

FHS
July 15, 2024
4:59 pm

Prostate-specific antigen (PSA) screening aims to identify men who may harbor potentially lethal prostate cancer, and those with high PSA results often require more extensive (and expensive) diagnostic testing to establish a diagnosis.

Fatty acid inhibitor plus chemo could improve treatment efficacy for breast cancer patients with brain metastases

A new study from the University of Michigan Health Rogel Cancer Center finds that giving a fatty acid inhibitor alongside chemotherapy could improve the treatment

July 30, 2024

Er-Kim extends agreement for Ascendis’ therapies in Eurasia

TransCon CNP, one of the therapies in the agreement, is currently in clinical development for achondroplasia. Credit: Louis Reed on Unsplash. Er-Kim has extended its

December 11, 2024

Smoking identified as key factor in accelerated cognitive decline

Smoking may be among the most important lifestyle factors affecting how quickly our cognitive skills decline as we age, suggests a new study led by

July 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.